Journal of Hepatology
Volume 50, Issue 2 , Pages 388-393 , February 2009

Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients

  • Mårten Werner

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Umeå University Hospital, SE-90185 Umeå, Sweden
    • Corresponding Author InformationCorresponding author.
    • ,
  • Sven Almer

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Linköping University hospital, Sweden
    • ,
  • Hanne Prytz

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, University Hospital of Lund, Sweden
    • ,
  • Stefan Lindgren

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Malmö University hospital, Sweden
    • ,
  • Sven Wallerstedt

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Sahlgrenska University Hospital at Östra Sjukhuset, Sweden
    • ,
  • Einar Björnsson

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Sahlgrenska University Hospital, at Sahlgrenska, Sweden
    • ,
  • Annika Bergquist

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Karolinska University Hospital at Huddinge, Sweden
    • ,
  • Hanna Sandberg-Gertzén

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Örebro University Hospital, Sweden
    • ,
  • Rolf Hultcrantz

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Karolinska University Hospital at Solna, Sweden
    • ,
  • Per Sangfelt

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Uppsala University Hospital, Sweden
    • ,
  • Ola Weiland

      Affiliations

    • Department of infectious diseases at Karolinska University Hospital at Huddinge, Sweden
    • ,
  • Åke Danielsson

      Affiliations

    • Department of Medicine Sections for Hepatology and Gastroenterology, Umeå University Hospital, SE-90185 Umeå, Sweden

Received 19 May 2008 ,Revised 20 August 2008 ,Accepted 23 August 2008.

References 

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576
  2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  3. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797–1801
  4. Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37:520–527
  5. Okuda H. Hepatocellular carcinoma development in cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:161–173
  6. Nishiyama R, Kanai T, Abe J, Hara R, Watahiki Y, Sakaguchi T, et al. Hepatocellular carcinoma associated with autoimmune hepatitis. J Hepatobiliary Pancreat Surg. 2004;11:215–219
  7. Meza-Junco J, Montano-Loza AJ, Martinez-Benitez B, Kimura-Hayama E. Hepatocellular carcinoma in patients with autoimmune liver diseases: two case reports and literature review. Ann Hepatol. 2007;6:122–126
  8. Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15:2069–2077
  9. Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, et al. The non-Hodgkin lyphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120:1–39
  10. Werner M, Prytz H, Ohlsson B, Almer S, Björnsson E, Bergquist A, et al. Epidemiology and the initial presentation of autoimmune hepatitis type 1 in Sweden. A nationwide study. Scand J Gastroenterol. 2008;43:1232–1240
  11. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938
  12. Werner M, Bjornsson E, Prytz H, Lindgren S, Almer S, Broome U, et al. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?. Scand J Gastroenterol. 2007;42:986–991
  13. Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm cancer registry. Int J Epidemiol. 1985;14:64–69
  14. Swedish National board of Health and Welfare. Quality of death cause register. In; 2007. www.socialstyrelsen.se.
  15. Swedish National board of Health and Welfare. Cancer incidence in Sweden 2006. In; 2006. www.socialstyrelsen.se.
  16. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol. 2007;4:424–432
  17. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  18. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99–103
  19. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36:321–327
  20. Loof L, Adami HO, Sparen P, Danielsson A, Eriksson LS, Hultcrantz R, et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology. 1994;20:101–104
  21. Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology. 1999;29:1425–1428
  22. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology. 1999;29:1396–1398

☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00699-5

doi: 10.1016/j.jhep.2008.08.022

Journal of Hepatology
Volume 50, Issue 2 , Pages 388-393 , February 2009

Article Tools